Skip to main content
Equibles

Avoro Capital Advisors LLC

Position in GPCR — Structure Therapeutics Inc.

CIK 1633313 NEW YORK, NY
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$351,836,636
+$35,858,885 QoQ
Shares Held
6,555,555
0.0% QoQ
Ownership
9.19%
of shares outstanding
% of Portfolio
3.16%
of 13F equity value
Holder Rank
#3
of 190 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Derivatives in GPCR

reported options exposure · as of Sep 30, 2025
CallValue
$7,000,000
CallShares
250,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Avoro Capital Advisors LLC holds $9,631,167,263 across 25 Biotechnology names. GPCR ranks #10 (3.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 5,111,111 $1,363,235,525
2 KRYS
Krystal Biotech, Inc.
 2,888,888 $1,073,713,002
3 MDGL
Madrigal Pharmaceuticals, Inc.
 1,833,333 $984,408,154
4 ARGX
Argenx SE
 1,000,000 $927,770,000
5 ARWR
Arrowhead Pharmaceuticals, Inc.
 11,355,555 $925,591,288
6 KYMR
Kymera Therapeutics, Inc.
 7,474,747 $857,129,238
7 RVMD
Revolution Medicines, Inc.
 2,297,000 $430,182,160
8 CYTK
Cytokinetics Inc
 4,999,999 $425,949,914

All Filings in GPCR

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $351,836,636 6,555,555
2026-03-31 $315,977,751 6,555,555
2025-12-31 $455,938,850 6,555,555
2025-09-30 $144,355,540 5,155,555
2025-09-30 $7,000,000 250,000
2023-12-31 $95,106,653 2,333,333
2023-09-30 $50,420,000 1,000,000